Sh Fosun Pharma reported CNY3.12B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Jiangsu Hengrui CNY 3.23B 111.82M Sep/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Sh Pharmaceutical CNY 4.66B 4.3B Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Wuxi Apptec CNY 778.61M 34.33M Sep/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025